Cite

HARVARD Citation

    Emami, M. et al. (2019). Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene. Advanced therapeutics. 2 (7), p. n/a. [Online]. 
  
Back to record